Pulmonary embolism and Weight decreased

Summary:

Weight decreased is found among people with Pulmonary embolism, especially for people who are female, 60+ old.

The study analyzes which people have Weight decreased with Pulmonary embolism. It is created by eHealthMe based on reports of 323 people who have Pulmonary embolism from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,958 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.

What is Weight decreased?

Weight decreased is found to be associated with 3,385 drugs and 4,753 conditions by eHealthMe. Check the latest studies of Weight decreased.

On Jul, 30, 2026

323 people who have Pulmonary Embolism and Weight Decreased are studied.

Would you have Weight decreased when you have Pulmonary embolism?

Gender of people who have Pulmonary embolism and experienced Weight decreased *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Pulmonary embolism (160,407 reports)
Weight decreased (364,522 reports)

All the drugs that are associated with Weight decreased:

Weight decreased (3,385 drugs)

All the conditions that are associated with Weight decreased:

Weight decreased (4,753 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weight decreased and Pulmonary embolism, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.